BSE Live
Oct 23, 16:01Prev. Close
2762.00
Open Price
2750.00
Bid Price (Qty.)
2752.00 (4)
Offer Price (Qty.)
2776.00 (2)
NSE Live
Oct 23, 15:59Prev. Close
2758.80
Open Price
2752.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
2760.70 (2)
| Cash Flow of GlaxoSmithKline Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 1,243.74 | 809.04 | 837.49 | 2,470.04 | 722.33 | |
| Net CashFlow From Operating Activities | 1,280.03 | 578.93 | 487.94 | 819.79 | 594.87 | |
| Net Cash Used In Investing Activities | -36.53 | 14.97 | 805.19 | -419.66 | 407.57 | |
| Net Cash Used From Financing Activities | -769.42 | -561.49 | -1,544.18 | -524.24 | -695.56 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 474.07 | 32.41 | -251.05 | -124.11 | 306.87 | |
| Cash And Cash Equivalents Begin of Year | 62.15 | 29.74 | 280.79 | 404.90 | 98.03 | |
| Cash And Cash Equivalents End Of Year | 536.22 | 62.15 | 29.74 | 280.79 | 404.90 |
12.08.2025
GlaxoSmithKline Consolidated June 2025 Net Sales at Rs 805.17 crore, down 1.16% Y-o-Y
01.08.2025
GlaxoSmithKline Standalone June 2025 Net Sales at Rs 804.83 crore, down 0.76% Y-o-Y
29.06.2025
01.06.2025